Lixte Biotechnology Inc.

NASDAQ: LIXT · Real-Time Price · USD
3.56
-0.34 (-8.72%)
At close: Aug 15, 2025, 3:59 PM
3.62
1.69%
After-hours: Aug 15, 2025, 05:16 PM EDT

Lixte Biotechnology Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost of Revenue
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Gross Profit
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Operating Income
-3.08M -3.31M -3.57M -3.99M -4.03M -4.69M -5.09M -5.7M -6.15M -6.03M -6.31M -6.7M -6.46M -6.65M -6.72M -5.6M -5.96M -4.6M
Interest Income
2.76K 4.63K 7.05K 10.48K 14.85K 15.33K 17.49K 20.52K 18.62K 16.1K 11.2K 4.35K 600.00 589.00 626.00 1.44K 1.31K 1.4K
Pretax Income
-3.09M -3.32M -3.59M -4M -4.03M -4.69M -5.09M -5.69M -6.15M -6.02M -6.31M -6.71M -6.47M -6.66M -6.73M -5.61M -5.97M -4.61M
Net Income
-3.09M -3.32M -3.59M -4M -4.03M -4.69M -5.09M -5.68M -6.14M -6.02M -6.3M -6.71M -6.47M -6.66M -6.73M -5.61M -5.97M -4.61M
Selling & General & Admin
2.53M 2.61M 2.85M 3.14M 3.41M 3.48M 3.81M 4.11M 4.43M 4.68M 4.69M 4.74M 4.54M 4.9M 4.98M 4.43M 4.22M 3M
Research & Development
548.57K 698.63K 726.23K 840.47K 611.33K 828.08K 898.1K 1.2M 1.34M 1.08M 1.35M 1.7M 1.65M 1.75M 1.74M 1.14M 1.72M 1.57M
Other Expenses
n/a -156 -156 -156 -156 n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 25.42K 28.81K 28.81K
Operating Expenses
3.08M 3.31M 3.57M 3.99M 4.03M 4.69M 5.09M 5.7M 6.15M 6.03M 6.31M 6.7M 6.46M 6.65M 6.72M 5.6M 5.96M 4.6M
Interest Expense
6.81K 12.77K 16.82K 22.53K 21.76K 19.56K 16.23K 9.72K 11.56K 10.24K 8.88K 9.71K 7.59K 7.81K 7.42K 6.63K 6.63K 5.78K
Selling & Marketing Expenses
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost & Expenses
3.08M 3.31M 3.57M 3.99M 4.03M 4.69M 5.09M 5.7M 6.15M 6.03M 6.31M 6.7M 6.46M 6.65M 6.72M 5.6M 5.96M 4.6M
Income Tax Expense
n/a n/a n/a n/a -1.02K -1.79K -417 -5.63K -7.21K -6.45K -7.75K -2.6K -147 -147 -219 -161 n/a -373
Shares Outstanding (Basic)
2.72M 2.47M 2.25M 2.25M 2.25M 2.25M 2.25M 2.07M 1.67M 1.66M 1.67M 1.66M 1.62M 1.37M 1.37M 1.37M 1.36M 1.28M
Shares Outstanding (Diluted)
2.72M 2.47M 2.25M 2.25M 2.25M 2.25M 2.25M 2.07M 1.67M 1.66M 1.67M 1.66M 1.62M 1.37M 1.37M 1.37M 1.36M 1.28M
EPS (Basic)
-1.29 -1.45 -1.59 -1.78 -1.83 -2.38 -2.77 -3.29 -3.69 -3.64 -4.02 -4.52 -4.53 -4.85 -5 -4.3 -4.83 -3.89
EPS (Diluted)
-1.29 -1.45 -1.59 -1.78 -1.83 -2.38 -2.77 -3.29 -3.69 -3.64 -4.02 -4.52 -4.53 -4.85 -5 -4.3 -4.83 -3.89
EBITDA
-4.04M -4.27M -4.54M -3.99M -4.02M -3.01M -2.04M -2.64M -1.62M -1.62M -1.63M -6.78K -1.25M -1.25M -1.24M -1.24M -1.61M -1.98M
EBIT
-3.08M -3.31M -3.57M -3.98M -4.01M -4.67M -5.07M -5.68M -6.13M -6.01M -6.3M -6.7M -6.46M -6.65M -6.72M -5.59M -5.96M -4.6M
Depreciation & Amortization
-259.78K -229.94K -949.16K 15.84K 17.56K 1.66M 3.04M 4.67M 6.15M 6.03M 6.31M 6.7M 6.46M 6.65M 6.72M 5.6M 5.96M 4.6M